Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Denali Therapeutics (DNLI) Tax Provisions (2019 - 2023)

Historic Tax Provisions for Denali Therapeutics (DNLI) over the last 5 years, with Q4 2023 value amounting to $30000.0.

  • Denali Therapeutics' Tax Provisions rose 60000.0% to $30000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $24000.0, marking a year-over-year increase of 10433.21%. This contributed to the annual value of $68000.0 for FY2024, which is 12666.67% up from last year.
  • According to the latest figures from Q4 2023, Denali Therapeutics' Tax Provisions is $30000.0, which was up 60000.0% from -$6000.0 recorded in Q4 2022.
  • Denali Therapeutics' 5-year Tax Provisions high stood at $823000.0 for Q4 2020, and its period low was -$575000.0 during Q4 2021.
  • Its 5-year average for Tax Provisions is -$4727.3, with a median of $27000.0 in 2022.
  • In the last 5 years, Denali Therapeutics' Tax Provisions skyrocketed by 99733.33% in 2020 and then crashed by 16986.63% in 2021.
  • Quarter analysis of 5 years shows Denali Therapeutics' Tax Provisions stood at $75000.0 in 2019, then skyrocketed by 997.33% to $823000.0 in 2020, then tumbled by 169.87% to -$575000.0 in 2021, then surged by 98.96% to -$6000.0 in 2022, then surged by 600.0% to $30000.0 in 2023.
  • Its Tax Provisions was $30000.0 in Q4 2023, compared to -$6000.0 in Q4 2022 and $27000.0 in Q2 2022.